Solesence, Inc. SLSN R2K

Consumer Defensive · Household & Personal Products · United States

Solesence, Inc., a science-driven company, provides engineered materials, formulation development, and commercial manufacturing services in the United States. The company engages in the manufacture and supply of surface engineered zinc oxide and titanium dioxide ingredients. It also provides skin care formulations with mineral-based UV protection enabled by proprietary active pharmaceutical ingredients; and skin health products, such as sunscreens and daily care products. The company sells products in various markets, including medical diagnostics, architectural coatings, industrial coating applications, abrasion-resistant additives, and plastics additives applications. It serves skin health, beauty, and wellness sectors. The company was formerly known as Nanophase Technologies Corporation and changed its name to Solesence, Inc. in March 2025. Solesence, Inc. was incorporated in 1989 and is headquartered in Romeoville, Illinois.

Market & Price

Market Cap

$86.88M

Current Price

$1.23

High / Low (52W)

$5.21 / $0.81

Beta

1.30

Valuation

Stock P/E

123.00

Industry PE

18.88

Forward P/E

PEG Ratio

Book Value

$0.25

Price to Book

4.92

P/S

1.44

EV/EBITDA

60.46

Dividend Yield

Profitability & Returns

ROCE

7.73%

ROE

5.88%

ROA

0.97%

Profit Margin

1.56%

Op Margin

-3.89%

EPS (Latest Qtr)

$-0.01

EPS (TTM)

$0.01

Balance Sheet & Liquidity

Debt/Equity

1.31

Quick Ratio

0.55

Current Ratio

2.08

Debt

$22.28M

Total Assets

$50.05M

Current Assets

$28.78M

Working Capital

$14.85M

Ownership

Promoter Holding

73.11%

Chg in Prom Hold

FII / Inst Holding

6.30%

Chg in FII Hold

Financial Snapshot

Enterprise Value

$108.59M

Total Revenue (TTM)

$60.40M

EBITDA

$1.80M

Free Cash Flow

$-3.87M

Operating Cash Flow

$171.00K

Shares Outstanding

70.63M

Gross Margin

26.52%

Payout Ratio

0.00%

Growth (CAGR)

Revenue 5Y

18.48%

Profit 5Y

56.08%

Revenue (YoY)

-11.40%

Earnings (YoY)

PROS

Compounding revenue at 18.5% over 5 years.
Profit CAGR of 56.1% over 5 years.

CONS

Trading at a high P/E of 123.0.
Trading 76.4% below its 52-week high.
In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Period: Metric:

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Consumer Defensive).

#	Name	CMP $	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	SLSN Solesence, Inc. R2K	1.23	123.00	$86.88M	-	7.73%	5.88%	18.48%	56.08%
2	WMT Walmart Inc. SPX	115.75	40.76	$922.64B	0.86%	18.21%	24.13%	5.27%	23.30%
3	COST Costco Wholesale Corporation NDXSPX	956.32	49.76	$424.27B	0.61%	27.44%	29.65%	6.64%	11.49%
4	KO The Coca-Cola Company SPX	79.01	24.85	$339.94B	2.68%	21.13%	43.37%	3.69%	11.16%
5	PG The Procter & Gamble Company SPX	143.56	21.02	$334.29B	2.97%	23.63%	31.11%	1.67%	2.71%
6	PM Philip Morris International Inc. SPX	177.38	24.98	$276.46B	3.31%	35.35%	-	8.57%	7.84%
7	PEP PepsiCo, Inc. NDXSPX	144.19	22.64	$197.10B	4.11%	15.23%	43.88%	2.83%	-2.57%
8	MO Altria Group, Inc. SPX	69.58	14.53	$116.19B	6.09%	40.85%	-	-0.89%	6.42%
9	MNST Monster Beverage Corporation NDXSPX	88.08	42.55	$86.14B	-	28.33%	26.65%	9.54%	16.94%

Quarterly Results

Figures in USD.

Metric	Jun 2013	Sep 2013	Mar 2014	Jun 2014	Sep 2014	Mar 2015	Jun 2015	Sep 2015	Mar 2016	Jun 2016	Sep 2016	Mar 2017	Jun 2017	Sep 2017	Mar 2018	Jun 2018	Sep 2018	Mar 2019	Jun 2019	Sep 2019	Mar 2020	Jun 2020	Sep 2020	Mar 2021	Jun 2021	Sep 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4.02M	3.75M	3.29M	3.07M	4.04M	4.33M	3.89M	7.07M	7.11M	7.92M	8.16M	11.22M	9.68M	9.46M	11.87M	7.96M	9.87M	13.05M	16.87M	14.62M	20.36M	14.60M	12.48M	12.96M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	11.24M	14.48M	11.23M	9.05M	9.62M
Gross Profit	849.00K	516.00K	708.00K	1.03M	796.00K	565.00K	992.00K	883.00K	456.00K	1.51M	680.00K	1.20M	1.20M	585.00K	410.00K	1.41M	1.06M	884.00K	832.00K	563.00K	1.03M	1.71M	1.69M	2.03M	2.51M	2.98M	2.17M	2.74M	2.49M	2.15M	3.67M	1.53M	3.58M	3.74M	6.10M	3.38M	5.88M	3.37M	3.43M	3.34M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3.13M	3.97M	4.15M	3.25M	3.84M
Operating Income	-461.00K	-632.00K	-427.00K	-69.00K	-348.00K	-603.00K	-90.00K	-151.00K	-606.00K	466.00K	-422.00K	57.00K	28.00K	-634.00K	-913.00K	97.00K	-124.00K	-470.00K	-597.00K	-815.00K	-43.00K	654.00K	552.00K	497.00K	960.00K	1.40M	105.00K	123.00K	-634.00K	-1.00M	579.00K	-1.22M	1.11M	1.05M	3.20M	256.00K	1.91M	-781.00K	186.00K	-504.00K
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	482.00K	3.37M	-556.00K	395.00K	-190.00K
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	176.00K	87.00K	339.00K	328.00K	263.00K
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	80.00K	3.06M	-1.12M	-154.00K	-766.00K
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	390.00K	0	-317.00K	0
Net Income	-452.00K	-633.00K	-429.00K	-70.00K	-349.00K	-606.00K	-93.00K	-155.00K	-610.00K	463.00K	-425.00K	46.00K	22.00K	-643.00K	-924.00K	88.00K	-136.00K	-513.00K	-647.00K	-862.00K	-167.00K	532.00K	430.00K	1.31M	41.00K	1.36M	62.00K	50.00K	-750.00K	-1.16M	333.00K	-1.44M	893.00K	856.00K	3.04M	80.00K	2.67M	-1.12M	163.00K	-766.00K
Diluted EPS	-	-	-	-	-	-	-	-	-	-	-	-	0.00	-0.02	-	0.00	0.00	-	-0.02	-0.02	0.00	0.01	0.01	0.03	0.00	0.03	0.00	0.00	-0.02	-0.02	0.01	-0.03	0.02	0.01	0.04	0.00	0.04	-0.02	0.00	-0.01
R&D Expense	453.00K	375.00K	337.00K	336.00K	316.00K	302.00K	343.00K	325.00K	301.00K	372.00K	386.00K	384.00K	476.00K	494.00K	558.00K	538.00K	416.00K	477.00K	485.00K	488.00K	372.00K	357.00K	405.00K	499.00K	536.00K	635.00K	666.00K	797.00K	848.00K	1.00M	991.00K	1.06M	910.00K	864.00K	970.00K	1.02M	955.00K	1.08M	-	1.04M

Profit & Loss (Annual)

Figures in USD.

Metric	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue	-	-	-	-	-	-	-	-	14.19M	12.51M	17.12M	-	37.32M	37.30M	52.35M	62.06M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	28.96M	29.47M	36.16M	46.00M
Gross Profit	2.53M	2.33M	2.64M	2.56M	2.83M	3.11M	3.24M	3.85M	3.29M	2.62M	5.99M	-	8.36M	7.83M	16.19M	16.06M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	10.62M	11.37M	11.06M	14.49M
Operating Income	-4.10M	-3.36M	-2.39M	-2.49M	-1.72M	-1.18M	-1.27M	-772.00K	-2.02M	-2.80M	1.49M	-	-2.26M	-3.55M	5.13M	1.57M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-1.69M	-2.80M	6.06M	3.69M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	382.00K	838.00K	670.00K	931.00K
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-2.64M	-4.38M	4.46M	1.86M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-17.00K	6.00K	227.00K	73.00K
Net Income	-4.08M	-3.36M	-2.39M	-2.48M	-1.73M	-1.19M	-1.28M	-789.00K	-2.08M	-3.01M	989.00K	-	-2.62M	-4.39M	4.24M	1.79M
Diluted EPS	-	-	-	-	-	-	-	-	-	-0.08	0.03	-	-0.05	-0.09	0.07	0.02
R&D Expense	1.61M	1.74M	1.63M	1.68M	1.34M	1.27M	1.55M	1.74M	2.06M	1.87M	1.57M	2.23M	3.04M	3.84M	3.84M	4.09M

Compounded Sales Growth

5 Years:	18.48%
1 Year:	-11.40%

Compounded Profit Growth

5 Years:	56.08%
1 Year:	-

Stock Price Performance

1 Year:	-68.13%
6 Months:	-45.33%
3 Months:	-3.91%
1 Month:	-5.38%

Balance Sheet (Annual)

Figures in USD.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets	-	13.48M	9.09M	9.65M	7.03M	5.73M	4.57M	4.84M	6.27M	6.57M	9.37M	13.54M	-	33.56M	32.88M	50.00M	50.05M
Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	16.62M	16.30M	29.35M	28.78M
Cash & Equivalents	3.90M	5.74M	2.69M	4.12M	3.28M	1.86M	1.27M	1.78M	1.96M	1.34M	1.19M	957.00K	-	2.19M	1.72M	1.41M	1.29M
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	8.84M	10.03M	20.27M	18.51M
Receivables	-	-	-	-	-	-	-	-	-	-	-	-	-	4.73M	3.47M	4.87M	6.84M
Total Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	27.91M	30.98M	35.06M	32.42M
Current Liabilities	-	2.26M	819.23K	1.20M	857.00K	976.00K	878.00K	1.30M	2.02M	3.64M	4.41M	6.78M	-	13.84M	15.59M	25.77M	13.93M
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	952.00K	1.00M	4.00M	6.00M	-	10.50M
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	18.11M	21.26M	15.30M	24.32M
Total Equity	14.09M	10.44M	7.48M	7.60M	5.37M	3.85M	2.86M	2.79M	3.23M	1.38M	1.51M	2.73M	-	5.65M	1.90M	14.95M	17.63M
Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-	-	-	49.32M	49.63M	70.10M	70.61M

Cash Flows (Annual)

Figures in USD.

Metric	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Operating Cash Flow	-1.45M	-2.92M	-599.50K	-	-	-	-241.00K	-960.00K	-1.34M	-2.78M	-2.06M	-	-1.65M	-2.01M	1.97M	-8.57M
Investing Cash Flow	3.30M	-138.43K	-167.24K	-	-	-	-165.00K	-72.00K	-160.00K	-740.00K	-878.00K	-	-2.82M	-1.05M	-4.56M	-2.14M
Financing Cash Flow	-8.47K	3.33K	2.20M	-	-	-	910.00K	1.21M	892.00K	3.37M	2.70M	-	6.00M	2.59M	2.27M	10.59M
Capital Expenditure	-253.45K	-85.99K	-152.00K	-279.00K	-216.00K	-280.00K	-128.00K	-209.00K	-160.00K	-740.00K	-878.00K	-	-2.82M	-1.05M	-4.56M	-2.14M
Free Cash Flow	-1.70M	-3.00M	-751.50K	-	-	-	-369.00K	-1.17M	-1.50M	-3.52M	-2.94M	-	-4.47M	-3.06M	-2.59M	-10.71M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-	-	-	1.53M	-464.00K	-313.00K	-121.00K

Ratios (Annual)

Figures in %.

Metric	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Gross Margin %	-	-	-	-	-	-	-	-	23.2%	20.9%	35.0%	-	22.4%	21.0%	30.9%	25.9%
Operating Margin %	-	-	-	-	-	-	-	-	-14.3%	-22.4%	8.7%	-	-6.1%	-9.5%	9.8%	2.5%
Net Margin %	-	-	-	-	-	-	-	-	-14.7%	-24.0%	5.8%	-	-7.0%	-11.8%	8.1%	2.9%
ROE %	-39.0%	-45.0%	-31.5%	-46.2%	-44.9%	-41.7%	-46.0%	-24.4%	-150.4%	-198.9%	36.2%	-	-46.4%	-230.8%	28.3%	10.2%
ROCE %	-36.5%	-40.7%	-28.3%	-40.4%	-36.2%	-31.9%	-35.8%	-18.2%	-69.0%	-56.3%	22.0%	-	-11.4%	-20.5%	21.2%	4.4%

Shareholding Pattern

Insiders

73.11%

Institutions

6.30%

Public Float

23.41%

Top Institutional Holders

#	Holder	% Held	Shares	Value
1	Blackrock Inc.	1.53%	1.07M	$1.31M
2	Vanguard Capital Management LLC	1.16%	811.71K	$998.40K
3	Geode Capital Management, LLC	0.64%	451.53K	$555.38K
4	State Street Corporation	0.58%	408.99K	$503.05K
5	Morgan Stanley	0.28%	194.78K	$239.58K
6	Northern Trust Corporation	0.20%	137.51K	$169.14K
7	Vanguard Fiduciary Trust Co	0.18%	123.01K	$151.30K
8	Vanguard Portfolio Management LLC	0.16%	112.41K	$138.26K
9	Charles Schwab Investment Management, Inc.	0.07%	47.39K	$58.29K
10	Bank Of New York Mellon Corporation	0.06%	44.07K	$54.21K

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for SLSN

No recent headlines available.

SLSN · Consumer Defensive

Solesence, Inc.

About

Key Facts

Sector	Consumer Defensive
Industry	Household & Personal Products
Headquarters	United States
Employees	115
Website	https://solesence.com

Press Esc or click outside to close.

Explore More

📊 Consumer Defensive Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks

Solesence, Inc. SLSN R2K

Market & Price

Valuation

Profitability & Returns

Balance Sheet & Liquidity

Ownership

Financial Snapshot

Growth (CAGR)

PROS

CONS

Price Chart

Technical Trend

Fundamental Growth

Peer comparison

Quarterly Results

Profit & Loss (Annual)

Compounded Sales Growth

Compounded Profit Growth

Stock Price Performance

Balance Sheet (Annual)

Cash Flows (Annual)

Ratios (Annual)

Shareholding Pattern

Top Institutional Holders

Analyst View

Latest News

Explore More